Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
PMDA is regarded among the most stringent regulatory bodies globally
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
